Adaptive Biotechnologies Corp — Director's Dealing 2019

Jul 2, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2019-07-01

Reporting Person: GOEL DAVID E. (Director, 10% Owner, See Remarks)
Reporting Person: Matrix Capital Management Company, LP (Director, 10% Owner, See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-01	Common Stock	C	200000	—	Acquired	200000	Indirect
2019-07-01	Common Stock	C	5893716	—	Acquired	6093716	Indirect
2019-07-01	Common Stock	C	11154116	—	Acquired	17247832	Indirect
2019-07-01	Common Stock	C	84359	—	Acquired	17332191	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-01	Series A Convertible Preferred Stock	$1.00	C	200000	Disposed		Common Stock (200000)	Indirect
2019-07-01	Series E-1 Convertible Preferred Stock	$6.0389	C	5893716	Disposed		Common Stock (5893716)	Indirect
2019-07-01	Series F Convertible Preferred Stock	$8.9653	C	11154116	Disposed		Common Stock (11154116)	Indirect
2019-07-01	Series F-1 Convertible Preferred Stock	$10.6686	C	84359	Disposed		Common Stock (84359)	Indirect

Footnotes

F1: All of the shares of convertible preferred stock automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The convertible preferred stock had no expiration date.

F2: The securities reported herein are held by Matrix Capital Management Master Fund, LP (the "Matrix Fund"). Matrix Capital Management Company, LP (the "Investment Manager"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel ("Mr. Goel", and together with the Investment Manager, the "Reporting Persons"), serves as the Managing General Partner of the Investment Manager.

F3: The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.